Optimization of the ELISA showed a capability of the assay to significantly distinguish HCoV-NL63 from HCoV-229E ( U = 27.50 , p < 0.001 ) and HCoV-OC43 ( U = 55.50 , p < 0.001 ) in coronavirus-characterized sera.